# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3293198 | B | Antagonist activity at EP2 receptor (unknown origin) expressed in rat C6 cells assessed as inhibition of PGE2-induced response | Homo sapiens | 92 | cell-based format | Scientific Literature | ||
2. | ALA3293199 | B | Antagonist activity at EP4 receptor (unknown origin) expressed in rat C6 cells assessed as inhibition of PGE2-induced response | Homo sapiens | 15 | cell-based format | Scientific Literature | ||
3. | ALA3293200 | B | Selectivity index, ratio of KB for EP4 receptor (unknown origin) to KB for EP2 receptor (unknown origin) | Homo sapiens | 15 | assay format | Scientific Literature | ||
4. | ALA3293201 | B | Antagonist activity at DP1 receptor (unknown origin) expressed in rat C6 cells by TR-FRET assay | Homo sapiens | 15 | cell-based format | Scientific Literature | ||
5. | ALA3293202 | B | Selectivity index, ratio of KB for DP1 receptor (unknown origin) to KB for EP2 receptor (unknown origin) | Homo sapiens | 15 | assay format | Scientific Literature | ||
6. | ALA3293203 | B | Antagonist activity at IP receptor (unknown origin) expressed in rat C6 cells by TR-FRET assay | Homo sapiens | 15 | cell-based format | Scientific Literature | ||
7. | ALA3293204 | B | Selectivity index, ratio of KB for IP receptor (unknown origin) to KB for EP2 receptor (unknown origin) | Homo sapiens | 15 | assay format | Scientific Literature | ||
8. | ALA3293205 | A | Cytotoxicity against rat C6 cells | Rattus norvegicus | 15 | cell-based format | Scientific Literature | ||
9. | ALA3293206 | A | Therapeutic index, ratio of CC50 for rat C6 cells to KB for EP2 receptor (unknown origin) | 15 | cell-based format | Scientific Literature | |||
10. | ALA3293207 | B | Competitive antagonist activity at human EP2 receptor assessed as inhibition of PGE2-induced response | Homo sapiens | 6 | single protein format | Scientific Literature | ||
11. | ALA3293208 | A | Metabolic stability of the compound in human liver microsomes assessed as compound remaining at 10 uM after 15 mins | Homo sapiens | 15 | assay format | Scientific Literature | ||
12. | ALA3293427 | A | Metabolic stability of the compound in human liver microsomes assessed as compound remaining at 10 uM after 30 mins | Homo sapiens | 15 | assay format | Scientific Literature | ||
13. | ALA3293428 | A | Metabolic stability of the compound in human liver microsomes assessed as compound remaining at 10 uM after 60 mins | Homo sapiens | 15 | assay format | Scientific Literature | ||
14. | ALA3293429 | A | Metabolic stability of the compound in mouse liver microsomes assessed as compound remaining at 10 uM after 15 mins | Mus musculus | 15 | assay format | Scientific Literature | ||
15. | ALA3293430 | A | Metabolic stability of the compound in mouse liver microsomes assessed as compound remaining at 10 uM after 30 mins | Mus musculus | 15 | assay format | Scientific Literature | ||
16. | ALA3293431 | A | Metabolic stability of the compound in mouse liver microsomes assessed as compound remaining at 10 uM after 60 mins | Mus musculus | 15 | assay format | Scientific Literature | ||
17. | ALA3293432 | P | Aqueous solubility of the compound by nephelometry method | 15 | small-molecule physicochemical format | Scientific Literature | |||
18. | ALA3293433 | A | Cmax in C57Bl/6 mouse at 5 mg/kg, ip | Mus musculus | 1 | organism-based format | Scientific Literature | ||
19. | ALA3293434 | A | AUClast in C57Bl/6 mouse at 5 mg/kg, ip | Mus musculus | 1 | organism-based format | Scientific Literature | ||
20. | ALA3293435 | A | AUC (infinity) in C57Bl/6 mouse at 5 mg/kg, ip | Mus musculus | 1 | organism-based format | Scientific Literature |